Related Articles
Cutaneous manifestations in inflammatory bowel disease (Review)
Risk of cardiovascular disease in inflammatory bowel disease (Review)
Calprotectin as a diagnostic tool for inflammatory bowel diseases (Review)
pH‑dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review)
Amelioration of the DSS‑induced colitis in mice by pretreatment with 4,4'‑diaponeurosporene‑producing Bacillus subtilis